Nations expanding their research programmes impose sweeping penalties for malpractice
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02517-1 India, Peru and Vietnam are rolling out policies that […]
Daily briefing: GLP-1 obesity drugs slow signs of ageing in mice
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02781-1 Mice on GLP-1s also performed better on cognitive tasks […]
[NEWS] HIV TRANSMISSION: Allegations Raise Fears of Backlash Against AIDS Prevention Strategy
Much to the dismay of AIDS researchers and clinicians around the world, the Associated Press (AP) ran a series last week that has reignited debate about the safety of one of the most heralded interventions in AIDS prevention: use of the drug nevirapine to prevent HIV transmission from an infected mother to her infant.
Author: Jon Cohen
[NEWS] HIGH-ENERGY PHYSICS: Report Slams SLAC’s Safety Practices
A Department of Energy investigation into a serious electrical accident this fall at the Stanford Linear Accelerator Center (SLAC) concludes that a routine disregard for safety regulations brought about the incident. The accident has led to the indefinite shutdown of the lab's accelerators, causing SLAC to lose ground to a Japanese laboratory engaged in the same type of research.
Author: Adrian Cho
[NEWS] CLINICAL TRIALS: Halt of Celebrex Study Threatens Drug’s Future, Other Trials
New research indicates Pfizer's COX-2 inhibitor Celebrex may cause increased risk of heart attacks and strokes, leading to the halting of some clinical trials involving the drug. Dozens of other COX-2 inhibitor trials are undergoing careful review. The scenario is strikingly similar to what happened this fall to Merck's COX-2 inhibitor Vioxx, which the Food and Drug Administration subsequently removed from the market.
Author: Jennifer Couzin
Ketone homologation via palladium-catalysed decarboxylative rearrangement
Nature, Published online: 03 September 2026; doi:10.1038/s41586-026-11091-5 Ketone homologation via palladium-catalysed decarboxylative rearrangement
Immune therapy engineered inside the body eases multiple sclerosis
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02765-1 Results from a small trial suggest a modified virus […]
Magic-mushroom compound blocks a severe side effect of chemotherapy, in mice
Nature, Published online: 03 September 2026; doi:10.1038/d41586-026-02744-6 Study shows that psilocybin acts on nerves to prevent […]